Agree, particularly the "...improves cognition...". That sure sounds definitive.
Except that when Dr Cummings says "promising", it reminds me of what Dr Ray said...promising and needs another study with 5000 patients and 500 MACE events. I sure hope we don't get another "underpowered" study!
Anyway, as long as the scientists agree that ABET works well enough on Dementia to create yet another reason for RVX to be bought out, I am good with whatever they say.
